Effect of allopurinol on mortality and hospitalisations in chronic heart failure: A retrospective cohort study

Heart

Volumn 87, Issue 3, 2002, Pages 229-234

  Struthers, A D ^a   Donnan, P T ^a   Lindsay, P ^a   McNaughton, D ^a   Broomhall, J ^a   MacDonald, T M ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; URIC ACID; XANTHINE OXIDASE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; URIC ACID BLOOD LEVEL;

EID: 0036180824     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.3.229     Document Type: Article

References (21)

1. Effect of local hyperuricaemia on endothelial function in the human forearm vascular bed
2. Elevated uric acid levels in hypercholesterolaemia are associated with coronary endothelial dysfunction
3. Uric acid is an independent predictor of impaired prognosis in patients with chronic heart failure
4. Relation of serum uric acid and 11.5 year mortality of middle-aged women: Findings of the Chicago Heart Association detection project in industry
5. Association of serum uric acid with all cause and cardiovascular disease mortality and incident MI in the MONICA Ausburg cohort
6. Serum uric acid and risk for cardiovascular disease and death: The Framlington heart study
7. Uric acid as an independent risk factor in the treatment of hypertension
8. Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow up study
9. Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries
10. Mediator-induced activation of xanthine oxidase in endothelial cells
11. Reactive oxygen metabolites and reperfusion injury: Aberrant triggering of reticuloendothelial function
12. Superoxide anion and hypoxia inactivate endothelium-derived relaxing factor
13. Superoxide anion is involved in the breakdown of endothelial-derived vascular relaxing factor
14. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolaemic but not in hypertensive patients
15. Allopurinol normalises endothelial dysfunction in type 2 diabetes with mild hypertension
16. Allopurinol improves endothelial dysfunction in chronic heart failure
17. The Tayside Medicines Monitoring Unit (MEMO): A record linkage study for pharmacovigilance
18. Social deprivation increases cardiac hospitalisations in chronic heart failure independently of disease severity and of diuretic non adherence
19. Ventricular dysfunction and the risk of stroke after myocardial infarction
20. Hormones to prevent coronary disease in women: When are observational studies adequate evidence?